Literature DB >> 17512406

Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors.

Thaddeus T Schug1, Daniel C Berry, Natacha S Shaw, Skylar N Travis, Noa Noy.   

Abstract

Transcriptional activation of the nuclear receptor RAR by retinoic acid (RA) often leads to inhibition of cell growth. However, in some tissues, RA promotes cell survival and hyperplasia, activities that are unlikely to be mediated by RAR. Here, we show that, in addition to functioning through RAR, RA activates the "orphan" nuclear receptor PPARbeta/delta, which, in turn, induces the expression of prosurvival genes. Partitioning of RA between the two receptors is regulated by the intracellular lipid binding proteins CRABP-II and FABP5. These proteins specifically deliver RA from the cytosol to nuclear RAR and PPARbeta/delta, respectively, thereby selectively enhancing the transcriptional activity of their cognate receptors. Consequently, RA functions through RAR and is a proapoptotic agent in cells with high CRABP-II/FABP5 ratio, but it signals through PPARbeta/delta and promotes survival in cells that highly express FABP5. Opposing effects of RA on cell growth thus emanate from alternate activation of two different nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512406      PMCID: PMC1948722          DOI: 10.1016/j.cell.2007.02.050

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  61 in total

1.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

2.  Nutrition Classics. The Journal of Experimental Medicine 42: 753-77, 1925. Tissue changes following deprivation of fat-soluble A vitamin. S. Burt Wolbach and Percy R. Howe.

Authors:  S B Wolbach; P R Howe
Journal:  Nutr Rev       Date:  1978-01       Impact factor: 7.110

3.  Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen.

Authors:  A K Verma; E A Conrad; R K Boutwell
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

4.  Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP.

Authors:  S Strickland; K K Smith; K R Marotti
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

5.  Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor beta/delta.

Authors:  Natacha Shaw; Morten Elholm; Noa Noy
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

6.  Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.

Authors:  Hirofumi Kawakubo; Jennifer L Carey; Elena Brachtel; Vandana Gupta; Jeffrey E Green; Paul D Walden; Shyamala Maheswaran
Journal:  Oncogene       Date:  2004-10-28       Impact factor: 9.867

Review 7.  Peroxisome proliferator-activated receptor-beta as a target for wound healing drugs.

Authors:  Nguan Soon Tan; Liliane Michalik; Béatrice Desvergne; Walter Wahli
Journal:  Expert Opin Ther Targets       Date:  2004-02       Impact factor: 6.902

Review 8.  Retinoic acid receptors and cancers.

Authors:  Dianne Robert Soprano; Pu Qin; Kenneth J Soprano
Journal:  Annu Rev Nutr       Date:  2004       Impact factor: 11.848

9.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.

Authors:  W J Muller; E Sinn; P K Pattengale; R Wallace; P Leder
Journal:  Cell       Date:  1988-07-01       Impact factor: 41.582

10.  Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

Authors:  C R King; M H Kraus; S A Aaronson
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

View more
  290 in total

1.  Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas.

Authors:  Benito Campos; Franz-Simon Centner; Justo Lorenzo Bermejo; Ramadan Ali; Katharina Dorsch; Feng Wan; Jörg Felsberg; Rezvan Ahmadi; Niels Grabe; Guido Reifenberger; Andreas Unterberg; Jürgen Burhenne; Christel Herold-Mende
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance.

Authors:  Barbara Cassani; Eduardo J Villablanca; Jaime De Calisto; Sen Wang; J Rodrigo Mora
Journal:  Mol Aspects Med       Date:  2011-11-22

3.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

Review 4.  Retinoid pathway and cancer therapeutics.

Authors:  Nathan Bushue; Yu-Jui Yvonne Wan
Journal:  Adv Drug Deliv Rev       Date:  2010-08-03       Impact factor: 15.470

5.  Structural basis for activation of fatty acid-binding protein 4.

Authors:  Richard E Gillilan; Stephen D Ayers; Noa Noy
Journal:  J Mol Biol       Date:  2007-08-02       Impact factor: 5.469

6.  The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease.

Authors:  Ian D Welch; Matthew F Cowan; Frank Beier; Tully M Underhill
Journal:  Arthritis Res Ther       Date:  2009-01-28       Impact factor: 5.156

Review 7.  Vitamin effects on the immune system: vitamins A and D take centre stage.

Authors:  J Rodrigo Mora; Makoto Iwata; Ulrich H von Andrian
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

8.  Docking simulations suggest that all-trans retinoic acid could bind to retinoid X receptors.

Authors:  Motonori Tsuji; Koichi Shudo; Hiroyuki Kagechika
Journal:  J Comput Aided Mol Des       Date:  2015-09-18       Impact factor: 3.686

Review 9.  Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment.

Authors:  Roisin M Connolly; Nguyen K Nguyen; Saraswati Sukumar
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

Review 10.  Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.

Authors:  Christina Y Yim; Pingping Mao; Michael J Spinella
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.